Redesign Science Company

Redesign Science is a computational chemistry company setting a new standard for early-stage, small molecule drug discovery. They efficiently simulate protein targets at the atomic level to reveal hidden, subtle drug opportunities that fall outside the capability and scope of alternative computational models.Basic science is proliferating with new understanding of biological pathways and disease mechanisms. New technologies are needed to solve emerging challenges and to commercialize new opportunities.

Total Funding: 17000000
Founded Date: 2017-01-01
Industry: Quantum Chemistry
Employee Number: 11-50
Last Funding Date: 2021-12-08
Funding Status: private
Headquarters: New York,New York,United States,North America
Super Industry: Quantum Science Applications
Funding Stage: Seed
Funding Total Value: 17000000
Last Funding Total Usd: 15000000
Last Funding Total Currency: USD
Last Funding Total Value: 15000000
Founders: David Rooklin,Haotian Li